The place of inhaled corticosteroids in COPD

Revue des maladies respiratoires
T ChinetG Jebrak

Abstract

Clinical trials have provided some evidence of a favorable effect of inhaled corticosteroids on the frequency of exacerbations and on the quality of life of patients with chronic obstructive pulmonary disease (COPD). In contrast, ICS have little or no impact on lung function decline and on mortality. Inhaled corticosteroids are recommended only in a minority of COPD patients, those with severe disease and repeated exacerbations and probably those with the COPD and asthma overlap syndrome. However, surveys indicate that these drugs are inappropriately prescribed in a large population of patients with COPD. Overtreatment with inhaled corticosteroids exposes these patients to an increased risk of potentially severe side-effects such as pneumonia, osteoporosis, and oropharyngeal candidiasis. Moreover, it represents a major waste of health-care spending. Primary care physicians as well as pulmonologists should be better aware of the benefits as well as the side-effects and costs of inhaled corticosteroids.

References

May 1, 1996·Chest·T E RenkemaD S Postma
Feb 1, 1997·American Journal of Respiratory and Critical Care Medicine·V M KeatingsP J Barnes
Jul 28, 1999·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·D C WeirP Sherwood Burge
Nov 11, 1999·American Journal of Respiratory and Critical Care Medicine·S V CulpittP J Barnes
Dec 10, 1999·American Journal of Respiratory and Critical Care Medicine·J J HospersD S Postma
Nov 9, 2000·American Journal of Respiratory and Critical Care Medicine·A PapiL M Fabbri
Jan 3, 2001·The New England Journal of Medicine·UNKNOWN Lung Health Study Research GroupMelissa Skeans
Feb 7, 2002·The European Respiratory Journal·N RocheP Terrioux
Jul 9, 2002·British Journal of Clinical Pharmacology·Nandini DendukuriJacques LeLorier
Sep 11, 2002·Journal of General Internal Medicine·David BlackburnMuhammad Mamdani
Nov 6, 2003·JAMA : the Journal of the American Medical Association·Don D SinNick R Anthonisen
Jun 25, 2004·The New England Journal of Medicine·Peter J Barnes
Oct 21, 2006·American Journal of Respiratory and Critical Care Medicine·Peter KardosClaus Vogelmeier
Feb 16, 2007·The European Respiratory Journal·R SivaI D Pavord
Feb 23, 2007·The New England Journal of Medicine·Peter M A CalverleyUNKNOWN TORCH investigators
Oct 6, 2007·American Journal of Respiratory and Critical Care Medicine·Jadwiga A WedzichaUNKNOWN INSPIRE Investigators
Mar 4, 2008·American Journal of Respiratory and Critical Care Medicine·Don D SinUNKNOWN ABC (Advair, Biomarkers in COPD) Investigators
Sep 27, 2008·Annual Review of Physiology·Peter J Barnes
Nov 27, 2008·JAMA : the Journal of the American Medical Association·M Bradley DrummondEddy Fan
Apr 21, 2009·The American Journal of Medicine·Christopher G SlatoreDavid H Au
Jul 2, 2009·The European Respiratory Journal·S Suissa, P J Barnes
Sep 11, 2009·Respirology : Official Journal of the Asian Pacific Society of Respirology·Mark WeatherallRichard Beasley
Dec 29, 2009·International Journal of Chronic Obstructive Pulmonary Disease·Niels H ChavannesOnno C P van Schayck
Feb 12, 2010·Revue des maladies respiratoires·G Jebrak, UNKNOWN Initiatives BPCO
May 14, 2010·International Journal of Chronic Obstructive Pulmonary Disease·Joseph SeamanRalph J Panos
Sep 28, 2010·The American Journal of Medicine·Samy SuissaPierre Ernst
Oct 5, 2010·American Journal of Respiratory and Critical Care Medicine·Paul BrassardPierre Ernst
Oct 29, 2011·Respiratory Medicine·Amir SharafkhanehUbaldo J Martin
Apr 10, 2012·Respiratory Medicine·Antonio Corrado, Andrea Rossi
Jul 10, 2013·International Journal of Chronic Obstructive Pulmonary Disease·Barbara P YawnKristijan H Kahler
Oct 17, 2013·Thorax·Samy SuissaPierre Ernst

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Related Papers

Primary Care Respiratory Journal : Journal of the General Practice Airways Group
David PriceAndrea Rossi
Pulmonary Pharmacology & Therapeutics
Oriol SibilaMarcos I Restrepo
Primary Care Respiratory Journal : Journal of the General Practice Airways Group
Josefin SundhKarin Lisspers
American Journal of Respiratory and Critical Care Medicine
Dennis ChenEric M Mortensen
Current Medical Research and Opinion
Julia Thornton SniderDana P Goldman
© 2021 Meta ULC. All rights reserved